One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol.
1/5 보강
📑 코퍼스 인용 관계
· 인용함 12
→ 이 논문이 인용한 논문 (1) ▾
- Validation of BLAST and BLAST-Mol Risk Models in Chronic Myelomonocytic Leukemia: Mayo-Hum… American journal of hematology · 2025
OpenAlex 토픽 ·
Acute Myeloid Leukemia Research
Chronic Lymphocytic Leukemia Research
Chronic Myeloid Leukemia Treatments
APA
Muhammad Yousuf, Saubia Fathima, et al. (2026). One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol.. Blood cancer journal, 16(1). https://doi.org/10.1038/s41408-026-01500-3
MLA
Muhammad Yousuf, et al.. "One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol.." Blood cancer journal, vol. 16, no. 1, 2026.
PMID
41935083 ↗
인용 관계
그래프 OA 노드: 0/1 (0%)
· 참조 0편 · 후속 0편